# Ofev

NDC: 0597-0145
Generic name: nintedanib
Labeler / Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20141015

FDA application: NDA205832

## Active ingredients

- NINTEDANIB ESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0597-0145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0597-0145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da1c9f37-779e-4682-816f-93d0faa4cfc9